No association between progesterone receptor gene ...[Cancer Epidemiol Biomarkers Prev. 2006] - PubMed Result

SearchDatabase nameforSearch term

Advanced Search (beta)

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1415-6. Links

No association between progesterone receptor gene +331G/A polymorphism and endometrial cancer.

Dossus L, Canzian F, Kaaks R, Boumertit A, Weiderpass E.

IARC, Lyon, France.

PMID: 16835347 [PubMed - indexed for MEDLINE]

Related Articles

A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. [Proc Natl Acad Sci U S A. 2002]
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. [Cancer Epidemiol Biomarkers Prev. 2004]
Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma. [J Pathol. 2005]
GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism. [Cancer Res. 2006]
Progesterone receptor (PROGINS) polymorphism and the risk of endometrial cancer development. [Int J Gynecol Cancer. 2007]
» See all Related Articles...

Patient Drug Information

Progesterone (Prometrium®) Progesterone is used as a part of hormone replacement therapy in women who have passed menopause (the change of life) and have not had a hysterectomy (surgery to remove the uterus). Hormone replacement therapy usually in...

» read more ...

Display Show